The Pro-Proliferative Effects of Nicotine and Its Underlying Mechanism on Rat Airway Smooth Muscle Cells

Fang He,Bing Li,Zhuxiang Zhao,Yumin Zhou,Guoping Hu,Weifeng Zou,Wei Hong,Yimin Zou,Changbin Jiang,Dongxing Zhao,Pixin Ran
DOI: https://doi.org/10.1371/journal.pone.0093508
IF: 3.7
2014-04-01
PLoS ONE
Abstract:Recent studies have shown that nicotine, a major component of cigarette smoke, can stimulate the proliferation of non-neuronal cells. Cigarette smoking can promote a variety of pulmonary and cardiovascular diseases, such as chronic obstructive pulmonary disease (COPD), atherosclerosis, and cancer. A predominant feature of COPD is airway remodeling, which includes increased airway smooth muscle (ASM) mass. The mechanisms underlying ASM remodeling in COPD have not yet been fully elucidated. Here, we show that nicotine induces a profound and time-dependent increase in DNA synthesis in rat airway smooth muscle cells (RASMCs) in vitro. Nicotine also significantly increased the number of RASMCs, which was associated with the increased expression of Cyclin D1, phosphorylation of the retinoblastoma protein (RB) and was dependent on the activation of Akt. The activation of Akt by nicotine occurred within minutes and depended upon the nicotinic acetylcholine receptors (nAchRs). Activated Akt increased the phosphorylation of downstream substrates such as GSK3β. Our data suggest that the binding of nicotine to the nAchRs on RASMCs can regulate cellular proliferation by activating the Akt pathway.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the effect of nicotine on the proliferation of airway smooth muscle cells (RASMCs) and its underlying mechanisms. Specifically, the study aims to clarify how nicotine promotes the proliferation of RASMCs by activating the Akt signaling pathway and to explore the relationship between this process and airway remodeling in chronic obstructive pulmonary disease (COPD). The following is a summary of the main content of the paper: ### Research Background - **COPD**: Chronic obstructive pulmonary disease is the 4th leading cause of death globally and is expected to become the 3rd leading cause of death. COPD is an inflammatory lung disease characterized by progressive and irreversible airflow limitation, involving changes in lung structure, such as emphysema and small - airway remodeling. - **Smoking**: Smoking is the main risk factor for the development of COPD. Tobacco smoke contains many toxic components, among which nicotine is the main addictive component and may play an important role in the development of COPD. - **The role of nicotine**: Recent studies have shown that nicotine can stimulate the proliferation of non - neuronal cells, such as aortic smooth muscle cells, bronchial epithelial cells and lung cancer cells. ### Research Hypothesis - The authors hypothesize that nicotine may activate the Akt signaling pathway by activating nicotinic acetylcholine receptors (nAchRs) on RASMCs, thereby playing an important role in the pathogenesis of COPD. ### Experimental Methods - **Cell culture**: RASMCs were isolated from rat airways and cultured in vitro. - **Nicotine treatment**: RASMCs were treated with different concentrations and durations of nicotine to observe its effects on cell proliferation and signaling pathways. - **Molecular biology techniques**: RT - PCR, Western Blot, immunofluorescence and other techniques were used to detect the expression and phosphorylation levels of related proteins. ### Main Results 1. **Nicotine promotes RASMCs proliferation**: - Nicotine treatment significantly increased the number of RASMCs, and this effect was time - dependent. - After nicotine treatment, the proportion of S - phase cells increased significantly, indicating enhanced DNA replication. 2. **Nicotine induces Cyclin D1 activity and RB phosphorylation**: - After nicotine treatment, the expression of Cyclin D1 and the phosphorylation of RB increased significantly. - Immunofluorescence analysis showed that the accumulation of Cyclin D1 in the nucleus increased significantly after nicotine treatment. 3. **Nicotine promotes RASMCs proliferation through nAchRs**: - When cells were treated with nAchRs antagonists MCA and MG624, it was found that these antagonists significantly inhibited cell proliferation, Cyclin D1 expression and RB phosphorylation caused by nicotine. 4. **Nicotine activates the Akt signaling pathway**: - After nicotine treatment, the phosphorylation of Akt at S473 site increased significantly, and this effect was time - and dose - dependent. - The PI3K inhibitor LY294002 completely inhibited Akt phosphorylation caused by nicotine, indicating that PI3K mediates the activation of Akt by nicotine. 5. **Nicotine activates the Akt signaling pathway through nAchRs**: - When cells were treated with nAchRs antagonists MCA and MG624, it was found that these antagonists significantly inhibited the phosphorylation of Akt and GSK3β caused by nicotine. 6. **The Akt signaling pathway promotes RASMCs proliferation**: - When cells were treated with the PI3K inhibitor LY294002 and the GSK3β inhibitor SB216763, it was found that these inhibitors significantly inhibited cell proliferation, Cyclin D1 expression and RB phosphorylation caused by nicotine. ### Conclusion - This study confirmed that nicotine activates the Akt signaling pathway by activating nAchRs on RASMCs, thereby promoting cell proliferation. This finding helps to understand the mechanism of nicotine in airway remodeling in COPD.